CoChat
Cited by 212

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Leptin in Leanness and Obesity

Open access
Perakakis, Nikolaos, Farr, Olivia M., Mantzoros, Christos S. · 2021 · Journal of the American College of Cardiology

Abstract

Leptin has emerged over the past 2 decades as a key hormone secreted by adipose tissue that conveys information on energy stores. Leptin is considered an important regulator of both neuroendocrine function and energy homeostasis. Numerous studies (mainly precLinicaL and much less in humans) have investigated the mechanisms of leptin’s actions both in the healthy state as well as in a wide range of metabolic diseases. In this review, the authors present leptin physiology and review the main findings from animal studies, observational and interventional studies, and clinical trials in humans that have investigated the role of leptin in metabolism and cardiometabolic diseases (energy deficiency, obesity, diabetes, cardiovascular diseases, nonalcoholic fatty liver disease). The authors discuss the similarities and discrepancies between animal and human biology and present clinical applications of leptin, directions for future research, and current approaches for the development of the next-generation leptin analogs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2020.11.069

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 101

  1. Boden, 1996, Effect of fasting on serum leptin in normal human subjects, J Clin Endocrinol Metab, 81, 3419
  2. Farr, 2015, Leptin and the brain: influences on brain development, cognitive functioning and psychiatric disorders, Metabolism, 64, 114, 10.1016/j.metabol.2014.07.004 · DOI
  3. Banks, 1996, Leptin enters the brain by a saturable system independent of insulin, Peptides, 17, 305, 10.1016/0196-9781(96)00025-3 · DOI · Paper page
  4. Faouzi, 2007, Differential accessibility of circulating leptin to individual hypothalamic sites, Endocrinology, 148, 5414, 10.1210/en.2007-0655 · DOI · Paper page
  5. Frank, 2011, Leptin therapy in a congenital leptin-deficient patient leads to acute and long-term changes in homeostatic, reward, and food-related brain areas, J Clin Endocrinol Metab, 96, E1283, 10.1210/jc.2010-2713 · DOI
  6. Farr, 2014, Leptin therapy alters appetite and neural responses to food stimuli in brain areas of leptin-sensitive subjects without altering brain structure, J Clin Endocrinol Metab, 99, E2529, 10.1210/jc.2014-2774 · DOI
  7. Hinkle, 2013, Effects of reduced weight maintenance and leptin repletion on functional connectivity of the hypothalamus in obese humans, PLoS One, 8, 10.1371/journal.pone.0059114 · DOI
  8. Chou, 2011, Leptin is an effective treatment for hypothalamic amenorrhea, Proc Natl Acad Sci U S A, 108, 6585, 10.1073/pnas.1015674108 · DOI · Paper page
  9. Bouzoni, 2020, Circulating profile of activin-follistatin-inhibin axis in women with hypothalamic amenorrhea in response to leptin treatment, Metabolism, 154392, 10.1016/j.metabol.2020.154392 · DOI
  10. Licinio, 2004, Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults, Proc Natl Acad Sci U S A, 101, 4531, 10.1073/pnas.0308767101 · DOI · Paper page
  11. Quennell, 2009, Leptin indirectly regulates gonadotropin-releasing hormone neuronal function, Endocrinology, 150, 2805, 10.1210/en.2008-1693 · DOI · Paper page
  12. Carro, 1997, Regulation of in vivo growth hormone secretion by leptin, Endocrinology, 138, 2203, 10.1210/endo.138.5.5238 · doi:10.1210/endo.138.5.5238 · Paper page
  13. Chan, 2006, Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans, Proc Natl Acad Sci U S A, 103, 8481, 10.1073/pnas.0505429103 · DOI · Paper page
  14. Pilitsi, 2019, Metabolism, 97, 32, 10.1016/j.metabol.2019.05.004 · DOI
  15. Dardeno, 2010, Leptin in human physiology and therapeutics, Front Neuroendocrinol, 31, 377, 10.1016/j.yfrne.2010.06.002 · DOI · Paper page
  16. van der Kroon, 1982, Congenital hypothyroidism in latent obese (ob/ob) mice, Int J Obes, 6, 83
  17. Chrysafi, 2020, Leptin alters energy intake and fat mass but not energy expenditure in lean subjects, Nat Commun, 11, 5145, 10.1038/s41467-020-18885-9 · DOI · Paper page
  18. Matarese, 2013, Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia, Proc Natl Acad Sci U S A, 110, E818, 10.1073/pnas.1214554110 · DOI
  19. Zhang, 1994, Positional cloning of the mouse obese gene and its human homologue, Nature, 372, 425, 10.1038/372425a0 · DOI · Paper page
  20. Lindstrom, 2007, The physiology of obese-hyperglycemic mice [ob/ob mice], ScientificWorldJournal, 7, 666, 10.1100/tsw.2007.117 · DOI · Paper page
  21. Cohen, 2001, Selective deletion of leptin receptor in neurons leads to obesity, J Clin Invest, 108, 1113, 10.1172/JCI200113914 · DOI
  22. Singh, 2009, Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels, Proc Natl Acad Sci U S A, 106, 13100, 10.1073/pnas.0903723106 · DOI
  23. Halaas, 1995, Weight-reducing effects of the plasma protein encoded by the obese gene, Science, 269, 543, 10.1126/science.7624777 · DOI · Paper page
  24. Weigle, 1995, Recombinant ob protein reduces feeding and body weight in the ob/ob mouse, J Clin Invest, 96, 2065, 10.1172/JCI118254 · DOI · Paper page
  25. Sloan, 2011, Central leptin signaling is required to normalize myocardial fatty acid oxidation rates in caloric-restricted ob/ob mice, Diabetes, 60, 1424, 10.2337/db10-1106 · DOI
  26. Erickson, 1996, Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y, Science, 274, 1704, 10.1126/science.274.5293.1704 · DOI · Paper page
  27. Vaisse, 1996, Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice, Nat Genet, 14, 95, 10.1038/ng0996-95 · DOI · Paper page
  28. Carpino, 2005, Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation, Dig Liver Dis, 37, 349, 10.1016/j.dld.2004.11.009 · DOI · Paper page
  29. Hwa, 1997, Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice, Am J Physiol, 272, R1204
  30. Commins, 1999, Induction of uncoupling protein expression in brown and white adipose tissue by leptin, Endocrinology, 140, 292, 10.1210/endo.140.1.6399 · DOI · Paper page
  31. Ukropec, 2006, Leptin is required for uncoupling protein-1-independent thermogenesis during cold stress, Endocrinology, 147, 2468, 10.1210/en.2005-1216 · DOI
  32. Beltowski, 2006, Leptin and atherosclerosis, Atherosclerosis, 189, 47, 10.1016/j.atherosclerosis.2006.03.003 · DOI · Paper page
  33. Konstantinides, 2001, Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity, J Clin Invest, 108, 1533, 10.1172/JCI13143 · DOI · Paper page
  34. Simonds, 2017, Does leptin cause an increase in blood pressure in animals and humans?, Curr Opin Nephrol Hypertens, 26, 20, 10.1097/MNH.0000000000000287 · DOI
  35. Masuzaki, 1995, Augmented expression of the obese gene in the adipose tissue from rats fed high-fat diet, Biochem Biophys Res Commun, 216, 355, 10.1006/bbrc.1995.2631 · DOI
  36. Cusin, 1996, The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals, Diabetes, 45, 1446, 10.2337/diab.45.10.1446 · DOI · Paper page
  37. Lu, 1994, Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor, Nature, 371, 799, 10.1038/371799a0 · DOI · Paper page
  38. Aizawa-Abe, 2000, Pathophysiological role of leptin in obesity-related hypertension, J Clin Invest, 105, 1243, 10.1172/JCI8341 · DOI · Paper page
  39. Simonds, 2014, Leptin mediates the increase in blood pressure associated with obesity, Cell, 159, 1404, 10.1016/j.cell.2014.10.058 · DOI · Paper page
  40. Harrison, 2019, Fluorescent blood-brain barrier tracing shows intact leptin transport in obese mice, Int J Obes (Lond), 43, 1305, 10.1038/s41366-018-0221-z · DOI
  41. Kleinert, 2018, Time-resolved hypothalamic open flow micro-perfusion reveals normal leptin transport across the blood-brain barrier in leptin resistant mice, Mol Metab, 13, 77, 10.1016/j.molmet.2018.04.008 · DOI
  42. Farr, 2016, Central nervous system regulation of eating: Insights from human brain imaging, Metabolism, 65, 699, 10.1016/j.metabol.2016.02.002 · DOI · Paper page
  43. Herz, 2019, Adipose tissue browning in mice and humans, J Endocrinol, 241, R97, 10.1530/JOE-18-0598 · DOI
  44. Considine, 1996, Serum immunoreactive-leptin concentrations in normal-weight and obese humans, N Engl J Med, 334, 292, 10.1056/NEJM199602013340503 · DOI · Paper page
  45. Marshall, 2000, Percent body fat and lean mass explain the gender difference in leptin: analysis and interpretation of leptin in Hispanic and non-Hispanic white adults, Obes Res, 8, 543, 10.1038/oby.2000.70 · DOI
  46. Bidulescu, 2020, Associations of leptin and adiponectin with incident type 2 diabetes and interactions among African Americans: the Jackson heart study, BMC Endocr Disord, 20, 31, 10.1186/s12902-020-0511-z · DOI
  47. Ostlund, 1996, Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates, J Clin Endocrinol Metab, 81, 3909
  48. Shankar, 2010, Positive relationship between plasma leptin level and hypertension, Hypertension, 56, 623, 10.1161/HYPERTENSIONAHA.109.148213 · DOI
  49. Ma, 2009, Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute Family Heart Study, Hypertension, 53, 473, 10.1161/HYPERTENSIONAHA.108.118133 · DOI
  50. Shanker, 2012, Relationship of adiponectin and leptin to coronary artery disease, classical cardiovascular risk factors and atherothrombotic biomarkers in the IARS cohort, Thromb Haemost, 108, 769, 10.1160/TH12-04-0263 · DOI
  51. Taneli, 2006, Increased serum leptin concentrations in patients with chronic stable angina pectoris and ST-elevated myocardial infarction, Angiology, 57, 267, 10.1177/000331970605700302 · DOI
  52. Azar, 2006, Percutaneous coronary intervention increases leptin and decreases adiponectin levels, Clin Endocrinol (Oxf), 65, 712, 10.1111/j.1365-2265.2006.02654.x · DOI
  53. Yang, 2017, Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis, PLoS One, 12
  54. Hoefle, 2007, Leptin, leptin soluble receptor and coronary atherosclerosis, Eur J Clin Invest, 37, 629, 10.1111/j.1365-2362.2007.01842.x · DOI
  55. Puurunen, 2017, Leptin predicts short-term major adverse cardiac events in patients with coronary artery disease, Ann Med, 49, 448, 10.1080/07853890.2017.1301678 · DOI
  56. Martin, 2015, Leptin and incident cardiovascular disease: the Multi-ethnic Study of Atherosclerosis (MESA), Atherosclerosis, 239, 67, 10.1016/j.atherosclerosis.2014.12.033 · DOI
  57. Seven, 2015, Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study, PLoS One, 10, 10.1371/journal.pone.0128987 · DOI
  58. Sierra-Johnson, 2007, Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population, Am J Cardiol, 100, 234, 10.1016/j.amjcard.2007.02.088 · DOI
  59. Wannamethee, 2013, Adiposity, adipokines, and risk of incident stroke in older men, Stroke, 44, 3, 10.1161/STROKEAHA.112.670331 · DOI
  60. Bevan, 2011, Adiponectin level as a consequence of genetic variation, but not leptin level or leptin: adiponectin ratio, is a risk factor for carotid intima-media thickness, Stroke, 42, 1510, 10.1161/STROKEAHA.110.602375 · DOI
  61. Saber, 2015, Serum leptin levels and the risk of stroke: the Framingham study, Stroke, 46, 2881, 10.1161/STROKEAHA.115.009463 · DOI
  62. Katsiki, 2018, Leptin, cardiovascular diseases and type 2 diabetes mellitus, Acta Pharmacol Sin, 39, 1176, 10.1038/aps.2018.40 · DOI · Paper page
  63. Perakakis, 2020, The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease, Metabolism, 111S, 154320, 10.1016/j.metabol.2020.154320 · DOI · Paper page
  64. Polyzos, 2020, Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD, J Clin Endocrinol Metab, 105, e399, 10.1210/clinem/dgz172 · DOI
  65. Polyzos, 2019, Fatty liver in lipodystrophy: a review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement, Metabolism, 96, 66, 10.1016/j.metabol.2019.05.001 · DOI
  66. Boutari, 2018, Association of adipokines with development and progression of nonalcoholic fatty liver disease, Endocrinol Metab (Seoul), 33, 33, 10.3803/EnM.2018.33.1.33 · DOI · Paper page
  67. Wong, 2004, Leptin hormonal kinetics in the fed state: effects of adiposity, age, and gender on endogenous leptin production and clearance rates, J Clin Endocrinol Metab, 89, 2672, 10.1210/jc.2003-031931 · DOI
  68. Chan, 2007, Pharmacokinetics of recombinant methionyl human leptin after subcutaneous administration: variation of concentration-dependent parameters according to assay, J Clin Endocrinol Metab, 92, 2307, 10.1210/jc.2006-2864 · DOI
  69. Chan, 2008, Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity, Clin Pharmacokinet, 47, 753, 10.2165/00003088-200847110-00006 · DOI
  70. Sienkiewicz, 2011, Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women, Metabolism, 60, 1211, 10.1016/j.metabol.2011.05.016 · DOI · Paper page
  71. Addy, 2003, Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy, J Clin Endocrinol Metab, 88, 627, 10.1210/jc.2002-020795 · DOI · Paper page
  72. Lee, 2006, Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy, J Clin Endocrinol Metab, 91, 2605, 10.1210/jc.2005-1545 · DOI · Paper page
  73. Tsoukas, 2015, Leptin in congenital and HIV-associated lipodystrophy, Metabolism, 64, 47, 10.1016/j.metabol.2014.07.017 · DOI
  74. Magkos, 2011, Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study, Metabolism, 60, 1045, 10.1016/j.metabol.2010.10.002 · DOI
  75. Brown, 2018, Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy, Endocrine, 60, 479, 10.1007/s12020-018-1589-1 · DOI
  76. Oral, 2019, Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy, Endocrine, 64, 500, 10.1007/s12020-019-01862-8 · DOI
  77. Brown, 2018, Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy, J Clin Invest, 128, 3504, 10.1172/JCI95476 · DOI
  78. Lawler, 2020, Leptin-mediated changes in the human metabolome, J Clin Endocrinol Metab, 105, 2541, 10.1210/clinem/dgaa251 · DOI
  79. Grewal, 2020, Metabolomic analysis of the effects of leptin replacement therapy in patients with lipodystrophy, J Endocr Soc, 4, bvz022, 10.1210/jendso/bvz022 · DOI
  80. Brown, 2015, Leptin does not mediate hypertension associated with human obesity, Cell, 162, 465, 10.1016/j.cell.2015.07.007 · DOI
  81. Muniyappa, 2014, Effects of leptin replacement therapy on pancreatic beta-cell function in patients with lipodystrophy, Diabetes Care, 37, 1101, 10.2337/dc13-2040 · DOI
  82. Oral, 2006, Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy, J Clin Endocrinol Metab, 91, 621, 10.1210/jc.2005-1220 · DOI
  83. Heymsfield, 1999, Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial, JAMA, 282, 1568, 10.1001/jama.282.16.1568 · DOI · Paper page
  84. Moon, 2015, Identification and saturable nature of signaling pathways induced by metreleptin in humans: comparative evaluation of in vivo, ex vivo, and in vitro administration, Diabetes, 64, 828, 10.2337/db14-0625 · DOI
  85. Mittendorfer, 2011, Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes, Diabetes, 60, 1474, 10.2337/db10-1302 · DOI
  86. Hukshorn, 2002, The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects, Int J Obes Relat Metab Disord, 26, 504, 10.1038/sj.ijo.0801952 · DOI
  87. Korner, 2013, Randomized double-blind placebo-controlled study of leptin administration after gastric bypass, Obesity (Silver Spring), 21, 951, 10.1002/oby.20433 · DOI · Paper page
  88. Lejeune, 2003, Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men, Int J Obes Relat Metab Disord, 27, 1494, 10.1038/sj.ijo.0802431 · DOI
  89. Kissileff, 2012, Leptin reverses declines in satiation in weight-reduced obese humans, Am J Clin Nutr, 95, 309, 10.3945/ajcn.111.012385 · DOI
  90. Rosenbaum, 2008, Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli, J Clin Invest, 118, 2583
  91. DePaoli, 2018, Efficacy of metreleptin for weight loss in overweight and obese adults with low leptin levels, Diabetes, 67, 296-LB, 10.2337/db18-296-LB · DOI
  92. Upadhyay, 2018, Pharmacotherapy of type 2 diabetes: an update, Metabolism, 78, 13, 10.1016/j.metabol.2017.08.010 · DOI · Paper page
  93. Moon, 2011, Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans, Diabetes Care, 34, 132, 10.2337/dc10-0518 · DOI
  94. Li, 2015, Hypothalamic amylin acts in concert with leptin to regulate food intake, Cell Metab, 22, 1059, 10.1016/j.cmet.2015.10.012 · DOI
  95. Ravussin, 2009, Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy, Obesity (Silver Spring), 17, 1736, 10.1038/oby.2009.184 · DOI · Paper page
  96. Yuan, 2017, Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity, J Control Release, 263, 172, 10.1016/j.jconrel.2017.03.029 · DOI
  97. Wang, 2018, [D-Leu-4]-OB3 and MA-[D-Leu-4]-OB3, small molecule synthetic peptide leptin mimetics, improve glycemic control in diet-induced obese (DIO) mice, Peptides, 101, 51, 10.1016/j.peptides.2017.12.012 · DOI
  98. Vauthier, 2017, Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling, Mol Metab, 6, 159, 10.1016/j.molmet.2016.10.009 · DOI
  99. Digenio, 2018, Antisense inhibition of protein tyrosine phosphatase 1B With IONIS-PTP-1BRx improves insulin sensitivity and reduces weight in overweight patients with type 2 diabetes, Diabetes Care, 41, 807, 10.2337/dc17-2132 · DOI
  100. Kars, 2010, Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women, Diabetes, 59, 1899, 10.2337/db10-0308 · DOI · Paper page
  101. von Schnurbein, 2019, Leptin is not essential for obesity-associated hypertension, Obes Facts, 12, 460, 10.1159/000501319 · DOI

Cited by

See all 212

Metadata

Authors
Perakakis, N., Farr, O. M., & Mantzoros, C. S.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2021-02
Volume
77
Issue
6
Pages
745-760
ISSN
0735-1097 (ISSN-L)
OpenAlex
W3128876677
Cited by
212
References
40
FWCI
9.86
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • Deutsche Forschungsgemeinschaft (389891681, PE 2431/3-1:1)
  • Novo Nordisk
  • National Institutes of Health (K24DK081913)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Leptin in Leanness and Obesity. https://app.cochat.ai/papers/10.1016/j.jacc.2020.11.069
The paper
Perakakis, N., Farr, O. M., & Mantzoros, C. S. (2021). Leptin in Leanness and Obesity. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2020.11.069

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.